Related Experiment Video
Updated: May 7, 2026

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
Published on: May 30, 2019
Clinical and Functional Heterogeneity of COPD Phenotypes: A Multicenter Study from Turkey (DIPTUR Study)
Tevfik Ozlu1, Ozlem Sengoren Dikis2, Fulden Cantas Turkis3
1Department of Pulmonary Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey.
Chronic obstructive pulmonary disease (COPD) phenotypes in Turkey vary significantly. Exacerbator phenotypes, like exacerbator with emphysema (EE) and exacerbator with chronic bronchitis (ECB), show higher disease burden and healthcare needs.
Area of Science:
- Pulmonology
- Clinical Medicine
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition.
- Phenotype-based classification may offer better insights into clinical burden and healthcare needs compared to standard GOLD categories.
- Understanding COPD phenotypes in specific populations, like Turkey, is crucial for tailored management.
Purpose of the Study:
- To determine the distribution of GesEPOC COPD phenotypes in Turkey.
- To compare demographic, clinical, functional, radiological, treatment, and healthcare utilization profiles across these phenotypes.
Main Methods:
- A multicenter, observational, cross-sectional study (DIPTUR) involving 894 stable COPD patients across 26 centers in Turkey.
- Patients were classified into GesEPOC phenotypes: exacerbator with emphysema (EE), exacerbator with chronic bronchitis (ECB), asthma-COPD overlap (ACO), and non-exacerbator (NE).
- Data collected included demographics, smoking status, comorbidities, pulmonary function tests, CT imaging, exacerbation history, and healthcare utilization.
Main Results:
- The phenotype distribution was NE (44.1%), ECB (26.2%), EE (20.5%), and ACO (9.3%).
- Exacerbator phenotypes (EE and ECB) exhibited lower pulmonary function, higher rates of dyspnea, greater comorbidity prevalence (hypertension, diabetes, heart failure), and increased healthcare utilization (hospitalizations, emergency admissions).
- Emphysematous changes were predominant in EE (91.7%), and long-term oxygen therapy was most common in EE (32.4%).
Conclusions:
- COPD phenotypes in Turkey display significant heterogeneity across clinical, functional, radiological, and healthcare utilization aspects.
- Exacerbator phenotypes, particularly EE and ECB, represent high-burden patient groups.
- Phenotype-oriented management and closer monitoring beyond the GOLD classification are supported by these findings.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations